[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-johnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030-IT":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":267,"suggestedPosts":343},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},145266,"Johnson & Johnson ha ottenuto l'approvazione nel Regno Unito per la sua pillola contro la psoriasi. Ecco dove potrebbe arrivare il titolo entro il 2030","2026-10-26T07:05:00","2026-10-26T01:24:23","\u003Cp>Johnson & Johnson ha aggiunto due notizie sui farmaci in due giorni, e il titolo è salito del 27,5% quest'anno. Le stime degli utili forward sono diminuite poiché la diluizione derivante dall'acquisizione ha colpito le previsioni. Il modello TIKR mostra cosa si compra con $263,81.\u003C\u002Fp>","\u003Ch3 id=\"h-k-ey-stats-for-johnson-amp-johnson-stock\" class=\"wp-block-heading\">Principali \u003Cstrong>Statistiche\u003C\u002Fstrong> per l'\u003Cstrong>Azione Johnson & Johnson\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Prezzo Attuale:\u003C\u002Fstrong> $263.81\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prezzo Obiettivo (Medio):\u003C\u002Fstrong> ~$342\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Obiettivo della Piazzola:\u003C\u002Fstrong> ~$279\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Potenziale Rendimento Totale:\u003C\u002Fstrong> ~30%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>TIR Annualizzato:\u003C\u002Fstrong> ~6% \u002F anno\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Ora Live: Scopri quanto potenziale rialzista potrebbero avere le tue azioni preferite utilizzando il nuovo Modello di Valutazione di TIKR (È gratuito)\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\"> >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-what-happened\" class=\"wp-block-heading\">Cosa è Successo?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Johnson & Johnson (\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?ref=k8i24l&cid=139677&?ref=tikrblog\">\u003Cstrong>JNJ\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong> ha chiuso a $263.81 il 23 ottobre, in rialzo del 27,5% nel 2026, e ha aggiunto due notizie sui farmaci nell'arco di due giorni. Il venerdì la Gran Bretagna ha approvato la sua pillola orale per la psoriasi Icotyde, e i nuovi dati su ERLEADA per il cancro alla prostata sono arrivati al Congresso ESMO il sabato, dopo la chiusura dei mercati per la settimana.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Le stime degli utili forward sono diminuite da giugno poiché J&J ha assorbito i costi delle acquisizioni, eppure le azioni scambiano a \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio\">circa 24 volte gli utili forward\u003C\u002Fa>, in aumento da circa 16 volte a settembre 2025. I nuovi dati devono sostenere questo multiplo in un 2027 che il Direttore Finanziario Joe Wolk afferma includerà una diluizione di $1,36 per azione.\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-erleada-data-and-an-icotyde-approval-back-a-growth-plan-built-without-deals\" class=\"wp-block-heading\">\u003Cstrong>I Dati su ERLEADA e l'Approvazione di Icotyde Sostengono un Piano di Crescita Costruito Senza Acquisizioni\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Al Congresso ESMO di Madrid il 24 ottobre, J&J ha riferito che ERLEADA più terapia ormonale, somministrata per sei mesi prima e dopo l'intervento chirurgico, \u003Ca href=\"https:\u002F\u002Fwww.jnj.com\u002Fmedia-center\u002Fpress-releases\u002Fjohnson-johnson-announces-erleada-apalutamide-treatment-before-and-after-surgery-reduces-risk-of-recurrence-or-death-by-62-versus-surgery-alone-in-high-risk-prostate-cancer\">ha ridotto il rischio di recidiva o morte del 62% rispetto alla sola chirurgia\u003C\u002Fa> nel cancro alla prostata ad alto rischio. Il sottostudio in aperto ha randomizzato 408 pazienti, e il regime non è approvato per questo uso. Il principale studio PROTEUS, presentato a maggio, ha mostrato un rischio inferiore del 20% di metastasi o morte rispetto alla sola terapia ormonale.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Un giorno prima, l'ente regolatore dei farmaci britannico \u003Ca href=\"https:\u002F\u002Fwww.yahoo.com\u002Fnews\u002Fscience\u002Farticles\u002Fuk-approves-j-js-oral-121013573.html\">ha approvato Icotyde\u003C\u002Fa>, la pillola una volta al giorno che J&J ha lanciato negli Stati Uniti quest'anno. Le azioni sono chiuse in calo dell'1,42% quel giorno, una seduta in cui anche Merck (MRK) ed Eli Lilly (LLY) sono scese e \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fjohnson-and-johnson-stock-smith-nephew-merger-talks-collapse\">le notizie dicevano che i colloqui di J&J sull'ortopedia con Smith & Nephew erano falliti\u003C\u002Fa>. Nella conference call del 13 ottobre, il Presidente e CEO Joaquin Duato ha detto che più di 20.000 pazienti statunitensi avevano iniziato Icotyde attraverso quasi 9.000 prescrittori, sebbene J&J non abbia divulgato le sue vendite.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Tom Cavanaugh, Vicepresidente Esecutivo e Presidente Mondiale di Innovative Medicine, ha detto che il farmaco per il cancro alla vescica INLEXZO ha superato i $90 milioni nel Q3, con nuovi inserimenti di pazienti in aumento del 45% rispetto al Q2. Ha indicato la sua popolazione attuale a circa 4.000 pazienti e ha fatto riferimento a popolazioni di studio più ampie di circa 15.000 e 50.000. Wolk ha detto che l'obiettivo di una crescita a doppia cifra entro la fine del decennio si basa su investimenti interni: \"Al momento attuale, non presuppone alcun aggiustamento inorganico.\"\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3023\" height=\"2015\" data-public-id=\"images\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3023,h_2015,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA\" alt=\"\" class=\"wp-post-145266 wp-image-145278\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792973382\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 3023w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3023px) 100vw, 3023px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Drawdown di Johnson & Johnson \u003Cstrong>(\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fmarkets?fid=1&?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR monitora 23 analisti su Johnson & Johnson. Quanti dicono \"Compra\"?\u003Cbr>\u003C\u002Fstrong> Vedi la ripartizione completa dei rating Compra, Mantieni e Vendi su Johnson & Johnson, insieme alle stime di ricavi e utili di Wall Street, tutto in un unico posto. Più di 500.000 investitori usano TIKR per ricercare azioni come questa. \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?ref=k8i24l&cid=139677&?ref=tikrblog\">Vedi i Rating degli Analisti di Johnson & Johnson\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-deal-dilution-cut-forward-eps-as-the-multiple-rose\" class=\"wp-block-heading\">\u003Cstrong>\u003Cstrong>La Diluizione da Acquisizioni Ha Tagliato gli EPS Forward Mentre il Multiplo Saliva\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>",1018,"it","\u002Fblog\u002Fjohnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030","johnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030","images\u002F3-20_145269da577\u002F3-20_145269da577","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792973012\u002Fimages\u002F3-20_145269da577\u002F3-20_145269da577.png?_i=AA",{"altText":237,"imageCredit":238},"Johnson & Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 2030","@Elisanth_ from Getty Images via Canva, @Elements Interactive from Pexels via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Wiltone Asuncion","wiltonetikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"David Hanson","davidtikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Recensioni delle azioni","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Johnson & Johnson added two pieces of drug news in two days, and the stock is up 27.5% this year. Forward earnings estimates fell as deal dilution hit guidance. The TIKR model shows what $263.81 buys.",{"title":260,"description":261,"twitterTitle":260,"twitterDescription":261,"author":240,"articlePublisher":262,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":263,"twitterData1":264,"ogTitle":260,"ogDescription":261,"ogUrl":232,"ogImage":235,"ogImageWidth":265,"ogImageHeight":266,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Johnson & Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 2030","Johnson & Johnson added two pieces of drug news in two days, and the stock is up 27.5% this year. Forward earnings estimates fell as deal dilution hit guidance. The TIKR model shows what $263.81 buys.","TIKR.com","Tempo di lettura stimato","4 minutes",1200,630,[268,283,298,313,328],{"id":255,"title":269,"date":270,"excerpt":271,"wordCount":272,"uri":273,"slug":274,"cloudinaryAssetId":275,"featuredImageOriginalUrl":276,"featuredImageMetadata":277,"author":278,"categories":280,"relatedPosts":282},"Le azioni di Nvidia sono scese di quasi l'8% a ottobre mentre i dubbi sulla spesa per l'IA hanno colpito i titoli tecnologici. Ecco dove potrebbe arrivare il titolo entro il 2031","2026-10-26 07:00:00","L'unica raccomandazione di vendita su Nvidia sostiene che il suo finanziamento ai clienti funzioni come uno sconto nascosto e che la sua liquidità netta sia diminuita di oltre la metà da gennaio. Il deposito documentale della stessa Nvidia mostra dove vanno le garanzie.",922,"\u002Fblog\u002Fnvidia-stock-fell-nearly-8-in-october-as-ai-spending-doubts-hit-tech-stocks-heres-where-the-stock-could-go-by-2031","nvidia-stock-fell-nearly-8-in-october-as-ai-spending-doubts-hit-tech-stocks-heres-where-the-stock-could-go-by-2031","images\u002F2-19_145268f960c\u002F2-19_145268f960c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792972994\u002Fimages\u002F2-19_145268f960c\u002F2-19_145268f960c.png?_i=AA",{"altText":269},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":279},[],[281],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":284,"date":285,"excerpt":286,"wordCount":287,"uri":288,"slug":289,"cloudinaryAssetId":290,"featuredImageOriginalUrl":291,"featuredImageMetadata":292,"author":293,"categories":295,"relatedPosts":297},"Il titolo di Meta è sceso del 7% in un giorno nonostante un superamento delle entrate. È il momento di vendere o di accumulare?","2026-10-24 20:50:00","Meta ha superato le previsioni sui ricavi e ha comunque perso il 7% in un giorno, poiché i timori sulla spesa per l'IA hanno colpito il settore tecnologico. La conference call sui risultati ha quantificato la riduzione dei costi di Muse.",995,"\u002Fblog\u002Fmeta-stock-fell-7-in-a-day-after-a-revenue-beat-time-to-sell-or-load-up","meta-stock-fell-7-in-a-day-after-a-revenue-beat-time-to-sell-or-load-up","images\u002F13-9_1449699b2ed\u002F13-9_1449699b2ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852857\u002Fimages\u002F13-9_1449699b2ed\u002F13-9_1449699b2ed.png?_i=AA",{"altText":284},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":294},[],[296],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":299,"date":300,"excerpt":301,"wordCount":302,"uri":303,"slug":304,"cloudinaryAssetId":305,"featuredImageOriginalUrl":306,"featuredImageMetadata":307,"author":308,"categories":310,"relatedPosts":312},"Netflix è sceso di quasi il 30% nel 2026. È il momento di vendere o di caricare?","2026-10-24 20:45:00","Il co-CEO di Netflix afferma che i suoi show negli Stati Uniti colpiranno doppi e tripli nel 2026, mentre il resto del mondo ha bisogno di fuoricampo. Con le azioni a $65.85 e valutate più vicino a Disney che a Spotify, il modello TIKR mostra per cosa sta pagando un acquirente.",1008,"\u002Fblog\u002Fnetflix-is-down-nearly-30-in-2026-time-to-sell-or-load-up","netflix-is-down-nearly-30-in-2026-time-to-sell-or-load-up","images\u002F12-9_144968b5caa\u002F12-9_144968b5caa","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852841\u002Fimages\u002F12-9_144968b5caa\u002F12-9_144968b5caa.png?_i=AA",{"altText":299},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":309},[],[311],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":314,"date":315,"excerpt":316,"wordCount":317,"uri":318,"slug":319,"cloudinaryAssetId":320,"featuredImageOriginalUrl":321,"featuredImageMetadata":322,"author":323,"categories":325,"relatedPosts":327},"Le azioni di Coca-Cola sono scese un giorno dopo aver raggiunto un massimo annuale. Ecco perché l'India conta il 27 ottobre","2026-10-24 20:40:00","Coca-Cola è scesa del 2,76% il 23 ottobre in un selloff generalizzato del mercato, un giorno dopo aver toccato un massimo annuale. Il suo ultimo rapporto ha mostrato che la regione Asia Pacifico ha aggiunto il maggior volume pur perdendo quote di mercato in India, e questa è la linea da seguire il 27 ottobre.",879,"\u002Fblog\u002Fcoca-cola-stock-fell-a-day-after-a-52-week-high-heres-why-india-matters-on-october-27","coca-cola-stock-fell-a-day-after-a-52-week-high-heres-why-india-matters-on-october-27","images\u002F11-10_14496728c3f\u002F11-10_14496728c3f","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852801\u002Fimages\u002F11-10_14496728c3f\u002F11-10_14496728c3f.png?_i=AA",{"altText":314},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":324},[],[326],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":329,"date":330,"excerpt":331,"wordCount":332,"uri":333,"slug":334,"cloudinaryAssetId":335,"featuredImageOriginalUrl":336,"featuredImageMetadata":337,"author":338,"categories":340,"relatedPosts":342},"ServiceNow vuole essere la numero 1 nella sicurezza. Ecco cosa deve dimostrare la sua scommessa da 7,75 miliardi di dollari su Armis il 28 ottobre","2026-10-24 20:35:00","Il CEO di ServiceNow afferma che l'azienda è l'ottavo fornitore di sicurezza aziendale e vuole diventare il numero uno. Le acquisizioni dietro questo obiettivo già gravano sui margini GAAP, e il 28 ottobre è il primo rapporto sugli utili da quando lo ha dichiarato.",965,"\u002Fblog\u002Fservicenow-wants-to-be-no-1-in-security-heres-what-its-7-75-billion-armis-bet-must-show-on-october-28","servicenow-wants-to-be-no-1-in-security-heres-what-its-7-75-billion-armis-bet-must-show-on-october-28","images\u002F10-13_1449664c7d7\u002F10-13_1449664c7d7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852762\u002Fimages\u002F10-13_1449664c7d7\u002F10-13_1449664c7d7.png?_i=AA",{"altText":329},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":339},[],[341],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[344,363,377,394,411],{"id":255,"title":345,"date":270,"excerpt":346,"wordCount":347,"uri":348,"slug":349,"cloudinaryAssetId":350,"featuredImageOriginalUrl":351,"featuredImageMetadata":352,"author":353,"categories":357,"relatedPosts":362},"SK Hynix Promette Restituzioni agli Azionisti il 28 Ottobre: Può Pagare un Dividendo Speciale da 12 Miliardi di Dollari?","SK Hynix potrebbe restituire agli azionisti circa il 70% del suo free cash flow degli ultimi dodici mesi. L'importo del dividendo annunciato mercoledì mostrerà se il denaro andrà agli azionisti o a Solidigm.",820,"\u002Fblog\u002Fsk-hynix-promises-shareholder-returns-on-october-28-can-it-pay-a-12-billion-special-dividend","sk-hynix-promises-shareholder-returns-on-october-28-can-it-pay-a-12-billion-special-dividend","images\u002FFEATURED-IMAGE-MAKER-1896\u002FFEATURED-IMAGE-MAKER-1896","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792994007\u002Fimages\u002FFEATURED-IMAGE-MAKER-1896\u002FFEATURED-IMAGE-MAKER-1896.png?_i=AA",{"altText":345},{"name":354,"slug":355,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":356},"Gian Estrada","giantikr",[],[358],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},"Investimenti generali","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":364,"date":270,"excerpt":365,"wordCount":366,"uri":367,"slug":368,"cloudinaryAssetId":369,"featuredImageOriginalUrl":370,"featuredImageMetadata":371,"author":372,"categories":374,"relatedPosts":376},"Musk Dice che SpaceX Ha Bloccato $40 Miliardi per i Chip, una Vittoria per Nvidia: \"Siamo Investment Grade\"","Musk afferma che SpaceX ha chiuso 40 miliardi di dollari di debito per le GPU. Per Nvidia, il denaro sostiene la domanda del 2027, ma si tratta di un accordo di gran lunga più piccolo di quanto suggerisce il titolo.",883,"\u002Fblog\u002Fmusk-says-spacex-locked-in-40-billion-for-chips-a-win-for-nvidia-were-investment-grade","musk-says-spacex-locked-in-40-billion-for-chips-a-win-for-nvidia-were-investment-grade","images\u002FFEATURED-IMAGE-MAKER-1897\u002FFEATURED-IMAGE-MAKER-1897","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792996223\u002Fimages\u002FFEATURED-IMAGE-MAKER-1897\u002FFEATURED-IMAGE-MAKER-1897.png?_i=AA",{"altText":364},{"name":354,"slug":355,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":373},[],[375],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":378,"date":379,"excerpt":380,"wordCount":381,"uri":382,"slug":383,"cloudinaryAssetId":384,"featuredImageOriginalUrl":385,"featuredImageMetadata":386,"author":387,"categories":391,"relatedPosts":393},"Bloom Energy è sceso del 44% rispetto al suo record di giugno. Ecco il dato che l'ha affondato dopo gli utili","2026-10-26 00:59:42","Mostrami i soldi, Bloom.",685,"\u002Fblog\u002Fbloom-energy-is-44-below-its-june-record-heres-the-number-that-sank-it-after-earnings","bloom-energy-is-44-below-its-june-record-heres-the-number-that-sank-it-after-earnings","images\u002F4-10_125274308d0\u002F4-10_125274308d0","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1787164294\u002Fimages\u002F4-10_125274308d0\u002F4-10_125274308d0.png?_i=AA",{"altText":378},{"name":388,"slug":389,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},"Rexielyn Diaz","rexietikr",[],[392],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":408,"relatedPosts":410},"Bank of America aumenta il prezzo obiettivo di ServiceNow prima degli utili del terzo trimestre","2026-10-26 00:38:00","Bank of America ha alzato il suo prezzo obiettivo per ServiceNow a $180 e ha mantenuto il rating Buy in vista degli utili del terzo trimestre il 28 ottobre. Ecco cosa tenere d'occhio.",616,"\u002Fblog\u002Fbank-of-america-raises-servicenow-price-target-third-quarter-earnings","bank-of-america-raises-servicenow-price-target-third-quarter-earnings","images\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792819580\u002Fimages\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva.png?_i=AA",{"altText":395},{"name":405,"slug":406,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":407},"Aditya Raghunath","adityatikr",[],[409],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":412,"date":413,"excerpt":414,"wordCount":415,"uri":416,"slug":417,"cloudinaryAssetId":418,"featuredImageOriginalUrl":419,"featuredImageMetadata":420,"author":421,"categories":425,"relatedPosts":427},"UnitedHealth guadagna il 3,5% dopo il target price di RBC a $498 mentre i titoli del Managed Care registrano un rally","2026-10-25 18:44:00","Una settimana dopo il superamento delle stime, gli analisti continuano a discutere sul multiplo",721,"\u002Fblog\u002Funitedhealth-gains-3-5-on-rbcs-498-price-target-as-managed-care-stocks-rally","unitedhealth-gains-3-5-on-rbcs-498-price-target-as-managed-care-stocks-rally","images\u002FUnitedHealth-Stock\u002FUnitedHealth-Stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792780120\u002Fimages\u002FUnitedHealth-Stock\u002FUnitedHealth-Stock.png?_i=AA",{"altText":412},{"name":422,"slug":423,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":424},"Bobby Sankhagowit","bobby",[],[426],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[]]